TP53 and colonic neoplasm: Since the results for treatment with a p53-specific agonist were consistent with metformin-induced proliferation inhibition and cycle arrest, metformin rescued the p53 inhibition caused by pft-α, which indicates that metformin can inhibit colon cancer HCT116 cell proliferation by activating p53.